Trulicity 1.5 mg/0.5 mL solution in a single-dose pen Images
Generic Name: dulaglutide
This medication has been identified as Trulicity 1.5 mg/0.5 mL solution in a single-dose pen. It is supplied by Eli Lilly and Company.
Trulicity is used in the treatment of Cardiovascular Risk Reduction; Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Risk cannot be ruled out during pregnancy. Trulicity 1.5 mg/0.5 mL solution in a single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Trulicity
- Generic Name
- dulaglutide
- Strength
- 1.5 mg/0.5 mL solution in a single-dose pen
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-1434
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro is used to treat type 2 diabetes in adults. It is a subcutaneous injection that can be ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Repatha
Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
More about Trulicity (dulaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (970)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.